A Delphi study to determine the epidemiology and clinical management of patients treated with HDMTX who develop methotrexate (MTX) delayed elimination in France, Germany, Italy, and the UK

Abstract Introduction High‐dose methotrexate (HDMTX) is administered for the treatment of some malignancies. Serious complications after the administration of HDMTX are rare, but occasionally MTX may precipitate in the renal tubes causing a delayed elimination leading to renal, multiorgan toxicities...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Stefan Bielack, Christopher P. Fox, Khê Hoang‐Xuan, Ariadna Giró‐Perafita, Carmelo Rizzari
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wiley 2024-01-01
Saila:	Health Science Reports
Gaiak:	acute kidney injury (AKI) epidemiology high‐dose methotrexate (HDMTX) methotrexate delayed elimination MTX toxicity clinical management
Sarrera elektronikoa:	https://doi.org/10.1002/hsr2.1749
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!